Q4 2024 Earnings Call Transcript March 4, 2025 Operator: Good afternoon, and welcome to Cumberland Pharmaceuticals Fourth Quarter 2024 Financial Report and Company Update. This call is being recorded ...
Explore how CPIX's revenue and expenses shape its earnings. Cumberland Pharmaceuticals shares are down 18% from a week ago. You still need to take note of risks, for example - Cumberland ...
StockNews.com upgraded shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday. Cumberland ...
US$6.48m (loss widened by 3.2% from FY 2023). US$0.46 loss per share (further deteriorated from US$0.44 loss in FY 2023).